Guidance on changing therapy choice in myelofibrosis

類似資料

• Current treatment algorithm for the management of patients with myelofibrosis, JAK inhibitors, and beyond
  著者:: Harrison, Claire N., 等
  出版事項: (2017)
• Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date
  著者:: Bassiony, Sarah, 等
  出版事項: (2020)
• Combination therapies in Myeloproliferative Neoplasms: why do we need them and how to identify potential winners?
  著者:: McLornan, Donal, 等
  出版事項: (2013)
• State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019
  著者:: McLornan, Donal P., 等
  出版事項: (2019)
• Exploitation of the neural-hematopoietic stem cell niche axis to treat myeloproliferative neoplasms
  著者:: Herlihy, Naoimh, 等
  出版事項: (2019)